HB 2217 Kansas House · 2017-2018 Regular Session

Standards governing the use and administration of emergency opioid antagonists.

Bill status signed all 4 stages cleared
Introduction
Jan 2017
Committee Review
Mar 2017
Senate Passage
Feb 2017
Signed into Law
May 2017
Introduced Jan 31, 2017 Signed May 1, 2017
Floor votes

How they voted

This bill passed the Senate by voice vote (no roll call recorded).
Full legislative history

Actions timeline

Total actions
20
Key actions
10
Committee
7
Amendments
2
May 1, 2017
Signed into law
Approved by Governor on Friday, April 7, 2017
legislature
Mar 28, 2017
Legislature · Passed
Final Action - Passed; Yea: 39 Nay: 0
legislature
Mar 27, 2017
Legislature · Passed
Committee of the Whole - Be passed
legislature
Mar 27, 2017
Introduced
Senator V. Schmidt raised a question of germaneness. The amendment was ruled not germane.
legislature
Mar 27, 2017
Introduced
Committee of the Whole - Motion to Amend - Offered by Senator Haley
legislature
Mar 27, 2017
Legislature · Passed
Committee of the Whole - Now working on
legislature
Mar 23, 2017
Legislature · Passed
Committee Report recommending bill be passed by Committee on Public Health and Welfare
legislature
Mar 7, 2017
Committee
Referred to Committee on Public Health and Welfare
legislature
Mar 6, 2017
Introduced
Received and Introduced
legislature
Feb 23, 2017
Legislature · Passed
Emergency Final Action - Passed as amended; Yea: 124 Nay: 0
legislature
Feb 23, 2017
Legislature · Passed
Committee of the Whole - Be passed as amended
legislature
Feb 23, 2017
Legislature · Passed
Committee of the Whole - Committee Report be adopted
legislature
Feb 23, 2017
Legislature · Passed
Committee of the Whole - Now working on
legislature
Feb 16, 2017
Legislature · Passed
Committee Report recommending bill be passed as amended by Committee on Health and Human Services
legislature
Feb 1, 2017
Committee
Referred to Committee on Health and Human Services
legislature
Jan 31, 2017
Introduced
Introduced
legislature
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.